2014 Hematology and Medical Oncology Best Practices

Transcription

2014 Hematology and
Medical Oncology
Best Practices
August 14 – 21, 2014
Hematology only: August 14-18
Medical Oncology only: August 17-21
Crystal Gateway Marriott
Arlington, VA
Course Director: Robert S. Siegel, M.D.
Register by June 15, 2014
and save an additional $150!
New this year: Course participants
will have access to online recordings
of the course for a modest fee.
Details coming soon.
www.HemOncBestPractices.com
2014 Hematology and Medical
Oncology Best Practices
With more than 20 years of experience, Hematology and Medical Oncology Best Practices course is one of the
longest-running courses covering hematology and medical oncology best practices. It also is the largest combined
hematology and medical oncology course in the United States, with more than 300 practicing clinicians attending each year.
Whether you are preparing for the certification/recertification exams, or simply seeking a comprehensive review of
evidence-based standards of care, you can benefit from our faculty’s expertise..
Early Bird
Early Bird
Postmarked by June 15, 2014
Tuition Fees
Physicians Physicians- Nurse Practitioners,
in-Training Physician Assistants,
Pharmacists, Others
(Non Physicians)
Hematology Only
(August 14-18, 2014)
Medical Oncology Only
(August 17-21, 2014)
Hematology & Medical
Oncology Full Course
(August 14-21, 2014)
$1,395
$1,195
$1,195
$1,395
$1,195
$1,195
$2,025
$1,895
$1,895
Regular
Regular
Postmarked after June 15, 2014
Tuition Fees
Physicians Physicians- Nurse Practitioners,
in-Training Physician Assistants,
Pharmacists, Others
(Non Physicians)
Hematology Only
(August 14-18, 2014)
Medical Oncology Only
(August 17-21, 2014)
Hematology & Medical
Oncology Full Course
(August 14-21, 2014)
Syllabus
Options
$1,545
$1,345
$1,345
$1,545
$1,345
$1,345
$2,175
$2,045
$2,045
Hematology
Medical
Only
Oncology Only
Hematology &
Medical Oncology
Downloadable PDF
$0
$0
$0
USB Drive with
PDF Syllabus
$15
$15
$20
Print Syllabus
$50
$50
$75
Print Syllabus and
USB Drive with PDF
$60
$60
$80
For information and to register, visit
www.HemOncBestPractices.com.
2 2014 Hematology and Medical Oncology Best Practices
ACCREDITATION
The George Washington University School of
Medicine and Health Sciences is accredited
by the Accreditation Council for Continuing
Medical Education to provide continuing
medical education for physicians.
Physician CME Credit
8-day Hematology and
Medical Oncology portion
The George Washington University School
of Medicine and Health Sciences designates
this live activity for a maximum of 70.25
AMA Physician Recognition Award Category
1 Credits™. Physicians should claim only
the credit commensurate with the extent of
their participation in the activity.
5-day Hematology portion
this live activity for a maximum of 44.5 AMA
Physician Recognition Award Category 1
Credits™. Physicians should claim only the
credit commensurate with the extent of their
participation in the activity.
5-day Medical Oncology portion
this live activity for a maximum of 41.75
AMA Physician Recognition Award Category
1 Credits™. Physicians should claim only
the credit commensurate with the extent of
their participation in the activity.
Credit Claim and
Course Evaluation
At the close of the course, participants
will be e-mailed a link to evaluate the
course and claim credit.
COURSE DIRECTOR AND FACULTY
COURSE DIRECTOR
Robert S. Siegel, M.D.
The George Washington University
GUEST FACULTY
David J. Adelstein, M.D.
Cleveland Clinic Lerner College
of Medicine of Case Western
Reserve University
Dean F. Bajorin, M.D.
Weil Medical College of Cornell
University
Kenneth A. Bauer, M.D.
Harvard University
Nancy Berliner, M.D.
Harvard University
F. Stephen Hodi, Jr., M.D.
Harvard University
S. Vincent Rajkumar, M.D.
Mayo Clinic Rochester
David H. Ilson, M.D., Ph.D.
Weill Medical College of Cornell
University
A. Koneti Rao, M.D.
Temple University
Bruce E. Johnson, M.D.
Harvard University
Margaret E. Rick, M.D.
Uniformed Services University of
the Health Sciences
Hagop Kantarjian, M.D.
The University of Texas MD
Anderson Cancer Center
Jerry L. Spivak, M.D.
Johns Hopkins University School
of Medicine
Gregory J. Kato, M.D.
University of Pittsburgh
David P. Steensma, M.D.
Harvard University
Nigel S. Key, M.D.
University of North Carolina at
Chapel Hill
F. Marc Stewart, M.D.
University of Washington
Charles D. Bolan, M.D. *
Thomas S. Kickler, M.D.
Johns Hopkins University
Edward Chu, M.D.
Hedy Lee Kindler, M.D.
University of Chicago
Daniel L. Clarke-Pearson, M.D.
University of North Carolina,
Chapel Hill
Patrick J. Loehrer, Sr., M.D.
Indiana University
Nancy E. Davidson, M.D.
Judy E. Garber, M.D., M.P.H.
Harvard University
Morie A. Gertz, M.D.
Victor R. Gordeuk, M.D.
University of Illinois
Ann Gramza, M.D.*
Daniel G. Haller, M.D.
University of Pennsylvania
John S. Macdonald, M.D.
New York Medical College
B. Gail Macik, M.D.
University of Virginia Health System
John L. Marshall, M.D.
Georgetown University
L. Jeffrey Medeiros, M.D.
Susan O’Brien, M.D.
Ayalew Tefferi, M.D.
James (Tate) Thigpen, M.D.
University of Mississippi Medical Center
Julie M. Vose, M.D., M.B.A.
University of Nebraska
Theodore (Ted) E. Warkentin, M.D.
McMaster University Hamilton,
Ontario, Canada
Neal S. Young, M.D.*
The George Washington
University School
of Medicine and Health
Sciences Faculty
James D. Ahlgren, M.D.
Jeanny B. Aragon-Ching, M.D.
Donald S. Karcher, M.D.
Vera Malkovska, M.D.
Imad A. Tabbara, M.D.
Bernhard L.(Bud)Wiedermann, M.D., M.A.
*Individual employees of the National Institutes of Health (NIH) have participated in the planning and development of the course, although the NIH is not
an official sponsor. The views expressed by the participants do not necessarily represent the opinions of the NIH, DHHS, or the Federal Government.
Faculty Disclosures
GW relies upon its faculty to provide information in a manner that is objective and free from bias. All instructors
are asked to disclose any real or apparent conflict of interest related to the context of their participation. Their
disclosure statements will be available for inspection. Each faculty member also will disclose discussions of
unlabeled or investigative use of any commercial product.
August 14 – 21, 2014 • Crystal Gateway Marriott, Arlington, VA 3
Agenda
Thursday, August 14, 2014
Friday, August 15, 2014
Hematology: Day 1
(Hem & HemOnc Participants)
Hematology: Day 2
8:00 AM
Biology of Hematopoiesis
Jerry L. Spivak, M.D.
8:00 AM
Mechanisms for Clotting
Nigel S. Key, M.D.
9:00 AM
Iron Deficiency and Overload
8:35 AM
The Hemophilias
Nigel S. Key, M.D.
10:00 AM
Break
10:15 AM
Hemoglobinopathies
9:20 AM
Von Willebrand’s Disease
Margaret Rick, M.D.
11:15 AM
Anemia of Chronic Illness
10:20 AM Acquired Disorders of Coagulation
Margaret Rick, M.D.
12:00 PM
Lunch (provided)
11:05 AM White Cell Disorders
Nancy Berliner, M.D.
12:20 PM Lunch Review Session:
Anemias and Sickle Cell Disease
Drs. Gordeuk, Kato, Malkovska,
and Siegel
2:00 PM
Porphyria
2:30 PM
Megaloblastic and
Sideroblastic Anemias
3:15 PM
Hemolytic Anemias
4:00 PM
Break
4:15 PM
RBC Enzymes, Membranes,
and Metabolism
5:00 PM
Sickling Disorder
Gregory J. Kato, M.D.
6:00 PM
Adjourn
10:05 AM Break
12:00 PM Lunch (provided)
WBC Disorders and Coagulopathy
Drs. Bauer, Macik, Rao, and Siegel
2:00 PM
Hypercoagulable States
Kenneth A. Bauer, M.D.
3:00 PM
Qualitative Platelet Defects
A. Koneti Rao, M.D.
3:45 PM
Break
4:00 PM
Oral Anticoagulants and
Antithrombotic Therapy
B. Gail Macik, M.D.
5:00 PM
Parenteral Antithrombotics and
Thrombolytic Therapy
B. Gail Macik, M.D.
5:30 PM
Adjourn
Saturday, August 16, 2014
Sunday, August 17, 2014
Hematology: Day 3
Hematologic Malignancies:
Day 1 (All Participants)
8:00 AM
Bone Marrow Failure
Neal Young, M.D.
8:00 AM
Pathology of Lymphomas
L. Jeffrey Medeiros, M.D.
9:00 AM
ITP and Drug Induced Thrombocytopenias
9:00 AM
Non-Hodgkin’s Lymphoma
9:45 AM
Break
10:00 AM Break
10:00 AM
Transfusion Medicine
10:15 AM Hodgkin’s Disease
10:55 AM
Platelet Alloimmunization
11:00 AM Chronic Lymphocytic Leukemia
Susan O’Brien, M.D.
11:30 AM
Consumptive Thrombohemorrhagic
Disorders
11:45 AM Acute Lymphocytic Leukemia
12:00 PM
Lunch (provided)
12:20 PM
Lunch Review Session:
Thrombocytopenias, Aplastic Anemia,
Anemias, and Myeloproliferative Disease
Drs. Kickler, Siegel, Tefferi, and Warkentin
2:00 PM
Prothrombotic Complications
of Anticoagulation
Lymphomas, CLL, ALL, CML,
Plasma Cell Disorders,
and M.D.S. Drs. Kantarjian, O’Brien, Rajkumar,
Siegel, Steensma, and Vose
3:00 PM
12:15 PM Lunch (provided)
2:15 PM
Chronic Myeloid Leukemia
Problems in Hemostaisis and Thrombosis
Drs. Siegel & Warkentin
3:00 PM
Multiple Myeloma,
Plasmacytoma, MGUS
S. Vincent Rajkumar, M.D.
3:30 PM
Break
4:00 PM
Break
3:45 PM
Hematologic Complications of Pregnancy
4:15 PM
Myelodysplasia David P. Steensma, M.D.
4:30 PM
Myeloproliferative Neoplasms
Ayalew A. Tefferi, M.D.
6:00 PM
Adjourn
5:00 PM
Waldenstom’s
Macroglobulinemia and
Amyloidosis Morie A. Gertz, M.D.
5:45 PM
Adjourn
Agenda (cont.)
Monday, August 18, 2014
tuesday, August 19, 2014
Hematologic Malignancies:
Day 2 (all Participants)
Medical Oncology: Day 1
(onc & HemOnc Participants only)
8:00 AM
Acute Myeloid Leukemia
8:00 AM
Head and Neck Cancer
David J. Adelstein, M.D.
9:00 AM
Bone Marrow Transplantation
F. Marc Stewart, M.D.
9:00 AM
Familial Cancer Syndromes
Judy E. Garber, M.D., M.P.H.
10:15 AM
Break
10:30 AM
ABO Incompatibility and Other
Transfusion-Related Issues in
Hematopoietic Transplantation
Charles D. Bolan, M.D.
9:45 AM
Small Cell Lung Cancer
10:30 AM
Break
11:15 AM
Pharmacology I
Edward Chu, M.D.
10:45 AM
Non-Small Cell Lung Cancer
12:15 PM
Lunch (provided)
11:35 AM
Adjuvant Therapy for Breast Cancer
Nancy E. Davidson, M.D.
12:35 PM
Lunch Review Session: AML,
Pharmacology, and BMT Drs. Chu, Siegel, Stewart,
and Tabbara
12:30 PM
Lunch (provided)
2:15 PM
Pharmacology II
Edward Chu, M.D.
12:50 PM
Breast Cancer, Lung Cancer,
and Neuro-Oncology Drs. Davidson and Siegel
3:00 PM
Pharmacology III
Edward Chu, M.D.
2:30 PM
Metastatic Breast Cancer
TBD
3:30 PM
Break
3:15 PM
Expert Panel: Problems in Treating
Breast Cancer
Drs. Davidson and Siegel
3:45 PM
Melanoma
F. Stephen Hodi, M.D.
3:45 PM
Break
4:30 PM
Preparing for the Boards
Bernhard L. (Bud) Wiedermann,
M.D., M.A.
4:00 PM
Neuro-Oncology
TBD
5:15 PM
Morphology Review
Donald S. Karcher, M.D.
4:30 PM
Metastatic Disease to the Brain,
Spine, Carcinomatous Meningitis TBD
5:00 PM
Endocrine Malignancies
Ann Gramza, M.D.
5:45 PM
Adjourn
6:00 PMAdjourn
End of Hematology 5-Day Course
Wednesday, August 20, 2014
thursday, August 21, 2014
medical Oncology: Day 2 (Onc
and HemOnc Participants only)
medical Oncology: Day 3 (Onc and
HemOnc Participants only)
8:00 AM
Testicular Cancer and Mediastinal
Germ Cell Tumors
Patrick J. Loehrer, Sr., M.D.
8:00 AM
Carcinoid Tumors, Carcinoid Syndrome
and Pancreatic Neuroendocrine Tumors
James D. Ahlgren, M.D.
8:45 AM
Renal Cell Cancer
8:30 AM
Gastric Cancer John S. Macdonald, M.D.
9:30 AM
Prostate Cancer
9:15 AM
Metastatic Colon and Rectal Cancer
John L. Marshall, M.D.
10:30 AM
Break
10:00 AM
Break
10:45 AM
Bladder Cancer
11:15 AM
Ovarian Cancer
10:15 AM
Adjuvant Therapy for Colon
and Rectal Cancer
12:15 PM
Lunch (provided)
11:15 AM
Anal Cancer
John S. Macdonald, M.D.
11:45 AM
Lunch (provided)
12:05 PM
GI, Sarcoma, and Palliative Care Drs. Aragon-Ching, Haller, Macdonald,
and Siegel
1:15 PM
Hepatobiliary Cancer
2:00 PM
Sarcomas
2:45 PM
Palliative Care
TBD
3:30 PM
Adjourn
End of Medical Oncology 5-Day Course
and Hematology & Medical Oncology
8-Day Course
GU, GYN and GI Tumors
Drs. Aragon-Ching, Bajorin, Kindler,
Loehrer, Thigpen, and Siegel
2:15 PM
Endometrial Cancer
2:45 PM
Cancer of the Cervix, Vulva,
Vagina and Gestational
Trophoblastic Tumors Daniel L. Clarke-Pearson, M.D.
3:45 PM
Break
4:00 PM
Esophageal Cancer
David H. Ilson, M.D., M.P.H.
4:45 PM
Pancreatic Cancer
5:30 PM
Mesothelioma
6:00 PM
Adjourn
*Agenda is subject to change.
The Office of Continuing Education in the Health Professions
The School of Medicine & Health Sciences
The George Washington University
2030 M Street NW, Room 4020
Washington, DC 20036
1-800-314-1423
[email protected]
PAID
U.S. Postage
Hagerstown, MD
Permit No. 93
Meeting Location and
Hotel Accommodations:
Crystal Gateway Marriott
1700 Jefferson Davis Highway
Arlington, VA 22202-3505
703-920-3230
$166 per night Room Rate!
Our special event room rate is $166 per night (single occupancy) plus tax.
This rate is good until our room block is full or until Monday, July 23, 2014.
The room rate also covers access to the fitness center and in-guest room
internet.
Reservations can be made by:
• Calling 1-888-236-2427 and referencing the 2014 George Washington
University Hematology and Medical Oncology Best Practices Course
• Visiting the course website under the “Hotel” section
www.HemOncBestPractices.com

2014 Hematology and Medical Oncology Best Practices

Transcription

Similar documents

Disseminated Intravascular Coagulation (DIC)